December 28, 2023
2 min read
In accordance to a modern examine, much more than half of the United States inhabitants qualified for semaglutide could shed at minimum 15% of their overall body fat soon after therapy with the medication.
Researchers believed that the medication could also avoid about 1.5 million CVD occasions about a 10 years if specified to all suitable sufferers in the U.S. It was just one of Healio’s best tales on obesity in 2023.
Other well known stories incorporate an editorial about the limitations of BMI as a measurement for obese and weight problems, suggestions for physicians who are prescribing anti-being overweight drugs and rising investigate on the idea of meals addiction.
Read through these and a lot more of Healio’s obesity coverage from 2023 down below:
Semaglutide could nearly halve obesity prevalence in US
Researchers believed that semaglutide could reduce the obesity prevalence in the United States by about 46% and prevent extra than 1.5 million CVD gatherings over 10 several years when provided to suitable people with chubby or weight problems. Go through a lot more.
‘Just a single number’: The issue with BMI
While BMI has prolonged been made use of in clinical exercise, numerous have not long ago questioned its success as a standalone evaluate for weight problems. Examine more.
New anti-obesity remedies: With wonderful electric power comes terrific accountability
Highly efficient new anti-obesity drugs these kinds of as semaglutide and tirzepatide have led to a sea adjust in expectations for the treatment of obesity, giving new hope to folks who have struggled with excessive excess weight for a long time. Go through far more.
Pounds decline in more mature nutritious grown ups related with improved mortality danger
Body weight decline of 5% or larger was associated with an improved threat for all-induce mortality amongst older wholesome adults, specially males, highlighting the importance of monitoring these patients for body weight changes, according to scientists. Read a lot more.
Food habit: ‘An region of ongoing scientific investigation’
Habit to very processed food items can lead to adverse wellbeing results, but small is recognized about why some people exhibit a better propensity for these foods and how to handle the issue in a most important care placing. Read additional.
AMA: Use other actions in addition to BMI when diagnosing obesity
The AMA Household of Delegates adopted a plan encouraging doctors to use BMI in conjunction with other valid measures when assessing clients for over weight or being overweight. Examine more.
Presenting fat loss in a favourable way connected to increased treatment method uptake
Pounds loss offered as a positive prospect by medical professionals was linked with better uptake of remedy and weight loss, a study printed in Annals of Interior Medication identified. Read extra.
Q&A: Gastroparesis from Ozempic, Wegovy ‘uncommon’
New studies in the media and legal motion have elevated queries about the security of well-liked fat-loss medications, specially about no matter whether they increase the danger for gatherings this kind of as gastroparesis and gastroenteritis. Study extra.
Q&A: In people with being overweight and kind 2 diabetes, OMA advocates to ‘treat obesity first’
The Being overweight Drugs Affiliation posted a new clinical observe statement encouraging clinicians to prioritize the therapy of obesity in patients who also have type 2 diabetes mellitus without the need of acute health issues. Study additional.
A seem at intermittent fasting: A prospective strategy for sufferers with weight problems
In the quest for practical strategies for dealing with being overweight, intermittent fasting has emerged as a well-known and perhaps transformative technique. Go through much more.
More Stories
What Medications Are Used to Treat Binge Eating?
19 Foods That Can Fight Sugar Cravings
Food Addiction Should Be Included in the DSM-6